Dyadic Logo Current.jpg
Dyadic’s C1 Platform Selected by the Vaccine and Immunotherapy Center (“VIC”) at Massachusetts General Hospital as Part of VIC’s $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases
05 oct. 2023 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic Logo Current.jpg
Dyadic Receives U.S. Patent for Manufacturing Seasonal and Pandemic Influenza Vaccines from its Proprietary C1 Protein Production Platform
18 avr. 2023 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
New logo.png
10 sept. 2018 09h00 HE | Amedica Corporation
SALT LAKE CITY, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announced the...
VaxInnate Logo
VaxInnate Initiates Phase 1b/2 Clinical Trial of Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, in Elderly
08 déc. 2014 08h00 HE | VaxInnate Corporation
Cranbury, NJ, Dec. 8, 2014 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a breakthrough vaccine technology platform, today announced the initiation of a double-blind,...
A Clinical Update on the Search for a Universal Flu Vaccine: Presentation in Washington, DC on January 30, 2014 in Conjunction With the American Society for Microbiology (ASM) Biodefense Conference
28 janv. 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Jan. 28, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today that the ASM Biodefense Meeting is scheduled for January 27-29, 2014 at the Washington Marriott...
Centers for Disease Control Urges Preparation for an Active Seasonal Flu Season
16 déc. 2013 08h30 HE | Hemispherx Biopharma, Inc.
PHILADELPHIA, Dec. 16, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announced that the company will accelerate its experimental program for a new...
Real-Life Contagion Stories: New APHL Book Reveals Heroism of H1N1 Pandemic Response and Recommends Key Measures for Continued Public Safety
08 sept. 2011 15h12 HE | Association of Public Health Laboratories
SILVER SPRING, MD--(Marketwire - Sep 8, 2011) - The Association of Public Health Laboratories (APHL) today released Lessons from a Virus: Public Health Laboratories Respond to the H1N1 Pandemic....
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corp.
25 janv. 2010 08h30 HE | Crystal Research Associates, LLC
NEW YORK, NY--(Marketwire - January 25, 2010) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO®) on CEL-SCI Corp. (NYSE Amex:...
New York City Depart
New York City Department of Education Leverages CyberShift's Workforce Management System for Rapid Implementation of H1N1 Vaccine Distribution Program
19 nov. 2009 13h27 HE | CyberShift
PARSIPPANY, NJ--(Marketwire - November 19, 2009) - CyberShift, a global provider of workforce management and expense management software and services, today announced that its Workforce Management...
MIT Enterprise Forum of Cambridge Presents "Vaccines and Global Health: New Technologies Create Global Opportunities"
04 nov. 2009 15h40 HE | MIT Enterprise Forum of Cambridge
CAMBRIDGE, MA--(Marketwire - November 4, 2009) - On November 9, the MIT Enterprise Forum of Cambridge will present a session on the development of new technologies for the research, development and...